MSD's Keytruda bags approval for new skin cancer indication
admin 26th June 2020 Uncategorised 0In trials Keytruda showed ‘meaningful efficacy’ with an objective response rate of 34%
More: MSD's Keytruda bags approval for new skin cancer indication
Source: News